You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Placebo and active control dose response study of rivoglitazone in type 2 diabetics

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Postoperative Wound Infection, Postoperative Complications, Surgical Site Infection Trial in Danville (Showering, Restriction of

Recruiting
  • Postoperative Wound Infection
  • +3 more
  • Showering
  • Restriction of Showering
  • Danville, Pennsylvania
    Geisinger Health
Aug 2, 2022

Stress Response, Mood State, Sleep Trial in Singapore (Postbiotic (Colonic-Delivery capsule), Postbiotic (Regular Administration

Recruiting
  • Stress Response
  • +3 more
  • Postbiotic (Colonic-Delivery capsule)
  • +2 more
  • Singapore, Singapore
    Human Development Research Centre, SICS, A*STAR
Oct 23, 2023

Advanced Solid Tumor Trial in Kuching (BL0020)

Not yet recruiting
  • Advanced Solid Tumor
  • Kuching, Malaysia
    Sarawak General Hospital
May 24, 2023

type1diabetes Trial in Columbus (Empagliflozin)

Not yet recruiting
  • type1diabetes
  • Columbus, Ohio
    Ohio State University
Jun 7, 2021

Vaccine Reaction Trial in New Haven (MicronJet, Fluzone® Quadrivalent)

Not yet recruiting
  • Vaccine Reaction
  • MicronJet
  • Fluzone® Quadrivalent
  • New Haven, Connecticut
    Church Street Research Unit
Sep 27, 2023

Hepatocellular Carcinoma Trial in Toronto, Milan, Pamplona (Tremelimumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Toronto, Ontario, Canada
  • +2 more
Jun 27, 2022

Ocular Hypertension Trial in Rochester (Latanoprostene Bunod, Placebo)

Recruiting
  • Ocular Hypertension
  • Latanoprostene Bunod
  • Placebo
  • Rochester, Minnesota
    Bausch Site 001
Sep 29, 2022

Pancreatic Cancer Trial in Netherlands (Cefuroxime, Metronidazole)

Not yet recruiting
  • Pancreatic Cancer
  • Leiden, Zuid Holland, Netherlands
  • +10 more
Mar 22, 2023

Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck Trial (WU-NK-101 - Dose Escalation, Cetuximab - Dose

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Squamous Cell Carcinoma of Head and Neck
  • WU-NK-101 - Dose Escalation
  • +3 more
  • (no location specified)
Dec 30, 2022

Looking at How Oral Semaglutide Works in People With Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Riyadh, Saudi Arabia
  • +1 more
Nov 17, 2022

Hereditary Angioedema, HAE Trial in Japan (BCX7353 capsules, Placebo oral capsule)

Completed
Has Results
  • Hereditary Angioedema, HAE
  • BCX7353 capsules
  • Placebo oral capsule
  • Chiba, Japan
  • +9 more
Jan 12, 2023

Chronic Pain, Rheumatoid Arthritis, Virtual Reality Trial in Istanbul (Immersive virtual reality, Non-immersive virtual reality)

Recruiting
  • Chronic Pain
  • +2 more
  • Immersive virtual reality
  • Non-immersive virtual reality
  • Istanbul, Turkey
    Acıbadem Mehmet Ali Aydınlar University
Nov 30, 2023

Moderate Hepatic Impairment, Severe Hepatic Impairment, Liver Diseases Trial in Miami Lakes, Orlando (Nitazoxanide)

Completed
  • Moderate Hepatic Impairment
  • +2 more
  • Miami Lakes, Florida
  • +1 more
Oct 12, 2022

NSCLC Trial in Shanghai (IN10018, Furmonertinib)

Recruiting
  • NSCLC
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 8, 2023

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

Recruiting
  • Advanced Colorectal Carcinoma
  • +15 more
  • Fermented Wheat Germ Extract
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jul 26, 2023

Non Hodgkin Lymphoma Trial in United States (AB-101, Rituximab, Interleukin-2)

Recruiting
  • Non Hodgkin Lymphoma
  • Birmingham, Alabama
  • +7 more
Dec 22, 2021

Primary Biliary Cholangitis Trial in Worldwide (Seladelpar 10 mg, Placebo, Seladelpar 5 mg)

Active, not recruiting
  • Primary Biliary Cholangitis
  • Seladelpar 10 mg
  • +2 more
  • Chandler, Arizona
  • +128 more
Jan 27, 2023

Crohn Disease Trial in Los Angeles (drug, procedure, biological)

Recruiting
  • Crohn Disease
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 23, 2022

Infertility Trial (Progesterone-IBSA Injectable Solution, Progesterone Vaginal Gel with Applicator, Placebo Vaginal gel with

Recruiting
  • Infertility
  • Progesterone-IBSA Injectable Solution
  • +3 more
  • Los Angeles, California
  • +14 more
Nov 10, 2022

Healthy Volunteers, Overweight, Obesity Trial in Groningen (NNC0480-0389, Semaglutide, Placebo (NNC0480-0389))

Completed
  • Healthy Volunteers
  • +3 more
  • Groningen, Netherlands
    Novo Nordisk Investigational Site
Mar 23, 2022

Anemia, End Stage Renal Disease Trial in United States (AKB-6548)

Completed
Has Results
  • Anemia
  • End Stage Renal Disease
  • El Granada, California
  • +15 more
Jun 7, 2022

Fungal Infection Trial in Ruddington ([14C]-APX001 Oral Solution, [14C]-APX001 Solution for Infusion)

Completed
  • Fungal Infection
  • [14C]-APX001 Oral Solution
  • [14C]-APX001 Solution for Infusion
  • Ruddington, Nottingham, United Kingdom
    Quotient Sciences
Sep 25, 2022

Perianal Fistula in Patients With Crohn's Disease Trial in Tehran (placenal MSC derived exosomes)

Active, not recruiting
  • Perianal Fistula in Patients With Crohn's Disease
  • placenal MSC derived exosomes
  • Tehran, Iran, Islamic Republic of
    Division of Colorectal Surgery, Department of Surgery, Tehran Un
Aug 11, 2022

Physical Activity Trial in Houston (implementation strategy for active learning to promote physical activity, Usual

Not yet recruiting
  • Physical Activity
  • implementation strategy for active learning to promote physical activity
  • Usual Implementation support
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 16, 2022

Polycystic Kidney Disease, Autosomal Dominant Trial in United States (RGLS4326)

Completed
  • Polycystic Kidney Disease, Autosomal Dominant
  • La Mesa, California
  • +11 more
Dec 14, 2021